It’s not the right time to quit: ASLAN Pharmaceuticals Ltd ADR (ASLN) Stock

Jefferies raised the price target for the ASLAN Pharmaceuticals Ltd ADR (NASDAQ:ASLN) stock to “a Buy”. The rating was released on July 09, 2021, according to finviz. We previously noted in another research note published on January 14, 2019 by H.C. Wainwright that reiterated the stock to a Buy with a price target of $8.50 […]